Cardiff Oncology Inc Dividends

The next dividend date for Cardiff Oncology Inc has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for Cardiff Oncology Inc (CRDF)

No Results.
DateDeclaration DateRecord DatePayment DateAmount
No Results.

More About Cardiff Oncology Inc

Country
USA
Full Time Employees
32

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated ongoing or planned trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, and triple negative breast cancer; CRDF-004, a Phase 2 open-label randomized multi-center clinical trial of onvansertib in combination with SoC FOLFIRI and bevacizumab or SoC FOLFOX and bevacizumab for the first-line treatment of patients with RAS-mutated mCRC; TROV-054, a Phase 1b/2 open-label multi-center clinical trial of onvansertib in combination with SoC FOLFIRI and bevacizumab for the second-line treatment of patients with KRAS-mutated mCRC; and CRDF-001, a Phase 2 open-label multi-center clinical trial of onvansertib in combination with nanoliposomal irinotecan leucovorin, and fluorouracil for second line treatment of patients with mPDAC. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was founded in 1999 and is headquartered in San Diego, California.

Owning Cardiff Oncology Inc Stock on the Dividend Date

If you own Cardiff Oncology Inc stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of Cardiff Oncology Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Cardiff Oncology Inc stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying Cardiff Oncology Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Cardiff Oncology Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More Cardiff Oncology Inc Dividends

You can contact us any time if you would like to ask questions about Cardiff Oncology Inc dividends or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.